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Abstract
The aim of this study was to describe the features of a large cohort of patients with postoperative mediastinitis, with particular regard to
Gram-negative bacteria (GNB), and assess their outcome. This bicentric retrospective cohort included all patients who were hospitalized in
the Intensive Care Unit with mediastinitis after cardiac surgery during a 9-year period. Three hundred and nine patients developed a
mediastinitis with a mean age of 65 years and a mean standard Euroscore of six points. Ninety-one patients (29.4%) developed a GNB
mediastinitis (GNBm). Of the 364 pathogens involved, 103 GNB were identiﬁed. GNBm were more frequently polymicrobial (44% versus
3.2%; p <0.001). Being female was the sole independent risk factor of GNBm in multivariate analysis. Initial antimicrobial therapy was
signiﬁcantly more frequently inappropriate with GNBm compared with other microorganisms (24.6% versus 1.9%; p <0.001). Independent
risk factors for inappropriateness of initial antimicrobial treatment were GNBm (OR = 8.58, 95%CI 2.53–29.02, p 0.0006), and polymicrobial
mediastinitis (OR = 4.52, 95%CI 1.68–12.12, p 0.0028). GNBm were associated with more drainage failure, secondary infection, need for
prolonged mechanical ventilation and/or use of vasopressors. Thirty-day hospital mortality was signiﬁcantly higher with GNBm (31.9 % versus
17.0%; p 0.004). GNBm was identiﬁed as an independent risk factor of hospital mortality (OR = 2.31, 95%CI 1.16–4.61, p 0.0179).
Keywords: Antibiotherapy, Gram-negative bacteria, mediastinitis, mortality, outcome
Original Submission: 21 March 2013; Revised Submission: 7 July 2013; Accepted: 13 August 2013
Editor: M. Grobusch
Article published online: 27 August 2013
Clin Microbiol Infect 2014; 20: O197–O202
10.1111/1469-0691.12369
Corresponding author: H. Charbonneau, Ho^pital Europeen
Georges Pompidou, Intensive care unit, 15-20 rue Leblanc, Paris
75015, France
E-mail: helenecharbs@hotmail.com
Introduction
Mediastinitis is a severe complication of cardiac surgery,
occurring in 0.25–2.9% of patients with sternotomy [1–5].
Although aggressive treatments including early surgical
debridement and closed aspirative catheter drainage have
dramatically improved the outcome, the mortality rate remains
high (7–40%) [3,6–9]. Epidemiological data of mediastinitis
have been reported in previous studies [1,2,10,11], but only a
few studies have investigated prognostic factors, mainly related
to intraoperative events [3,12]. Furthermore, the limited
number of cases in some studies and the heterogeneity of
surgical management make the assessment of the prognostic
factors difﬁcult.
Even though previous studies have investigated the man-
agement of anti-infectious therapies, such as the use of
antibiotic prophylaxis or the appropriateness of empirical
antibiomicrobial therapy, microbiological data and particularly
Gram-negative bacteria (GNB) mediastinitis have rarely been
studied as prognostic factors. GNB could be a frequent cause
of inappropriate treatment with adverse prognostic potential
because these pathogens are underestimated in mediastinitis
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[2,3,5,13]. Thus far, no studies have systematically studied the
impact of GNB infections on the outcome of mediastinitis. The
aim of this study was to describe the demographic, clinical and
microbiological features of a large cohort of patients with
postoperative mediastinitis and more particularly to assess the
outcome of GNB mediastinitis (GNBm).
Materials and Methods
Study population
This retrospective cohort analysis was conducted in the
intensive care units (ICU) of two hospitals: Europeen Georges
Pompidou, Paris, France and Centre Cardiologique du Nord,
Saint-Denis, France. Patients admitted to the ICU for medi-
astinitis after cardiac surgery were included over a period of
9 years (January 2000 to December 2008). The diagnosis of
mediastinitis was based on the Centers for Disease Control
deﬁnitions [14] and deﬁned as the presence of a purulent
organ space infection of the mediastinum that was conﬁrmed
by sternal debridement. In both institutions, a speciﬁc com-
mittee composed of surgeons, microbiologists, intensivists and
hygienists validated mediastinitis cases twice a year. We
retrospectively analysed the data of these prospectively
validated cases. GNBm was deﬁned by the identiﬁcation of
at least one GNB in the culture samples.
Patient management
For initial surgery, antimicrobial prophylaxis measures were
the same in both institutions; cefamandole was infused within
1 h before the incision, and reinfusion was performed every
2 h if the surgery lasted for more than 4 h. Vancomycin was
used in patients allergic to b-lactams or for patients
hospitalized in the ICU for more than 7 days before the
surgery. For mediastinitis, surgical and medical management
were similar in both ICU. Surgical care consisted of a
mediastinal exploration via sternotomy. Several swabs and
collections of samples were performed for bacteriological
analysis. Subsequently, any ﬁbrin deposits were removed and
necrotized areas of the sternum were resected. As previ-
ously described [7,8], three to ten Redon catheters for
aspirating drainage were inserted in infected areas, including
the mediastinal cavity and dissected subcutaneous chest wall
area. Each catheter was connected to a bottle in which a
negative pressure was maintained (Drainobag 150; B. Braun
Melsungen AG, Melsungen, Germany). The efﬂuents col-
lected in each bottle were bacteriologically cultured three
times a week. The catheters were progressively removed
after two consecutive negative culture results if the daily
efﬂuent volume was less than 5 mL. In addition, the usual
ICU treatments (mechanical ventilation, vasopressors or
renal replacement therapy) were administered as needed;
medical care consisted of an intravenous infusion of antibi-
otics.
Microbiological methods and antibiotherapy
For each patient, direct examination with Gram-staining and
cultures of mediastinal needle aspirates and/or surgical mate-
rial were performed. The initial antibiotic therapy was
determined based on a direct examination of Gram-staining.
Vancomycin was administered when Gram-positive cocci were
identiﬁed, b-lactams were administered when GNB were
identiﬁed. In both case, gentamicin was associated. When
Gram-staining was not conclusive, b-lactams, vancomycin and
gentamicin were administered. The choice of b-lactams
depended on host factors, including the risk for infection with
antibiotic-resistant pathogens, with guidance from local sus-
ceptibility patterns. This therapy was subsequently modiﬁed, if
necessary, according to the antibiogram of the responsible
microorganisms. Antibiotic therapy was prolonged 6 weeks
after the last surgical debridement.
The initial antimicrobial therapy was considered ‘appropri-
ate’ if the treatment regimen included at least one antibiotic
active in vitro against identiﬁed pathogens, except aminoglyco-
sides alone, and if the dosage and route of administration
conformed to current medical standards. We considered
antimicrobial therapy ‘inappropriate’ if the drugs used did not
have in vitro activity against the isolated strain, if the patient did
not receive any antibiotics initially.
Data collection
Baseline clinical and surgical data including the following were
collected: age, gender, body mass index, comorbidities
(chronic pulmonary disease, extracardiac arteriopathy, diabe-
tes, preoperative renal insufﬁciency), clinical risk factors of
mediastinitis (type of surgery, bypass time and postoperative
emergency surgery for bleeding). The perioperative mortality
risk status was assessed with the standard European System
for Cardiac Operative Risk Evaluation (EuroSCORE) [15].
Collected data related to mediastinitis were time to onset
(deﬁned as the time between ﬁrst surgical procedure and
mediastinal debridement), isolated pathogens, mediastini-
tis-associated bacteraemia, and appropriate or inappropriate
characteristics of empirical antimicrobial therapy. Time to
onset was classiﬁed in two groups: before and after 14 days
[16]. Isolated pathogens were independently analysed. The
resistant bacteria included methicillin-resistant Staphylococcus
aureus (MRSA) and GNB resistant to one or more of
extended-spectrum cephalosporins, one of aminoglycosides
(tobramycin, amikacin or gentamicin) and ciproﬂoxacin.
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Outcome measures
Outcome data included the in-hospital survival rates, the
length of catheter drainage, the ICU length of stay, the
incidence of a complicated ICU course (deﬁned as the need for
mechanical ventilation for more than 3 days and/or the use of
vasopressors), failure of drainage (deﬁned as secondarily
infected Redon catheters and/or failure of aspirating Redon
catheters), and mediastinitis-associated endocarditis.
This study complied with the Declaration of Helsinki. The
data base concerned had previously been approved by the
French national commission for computerized ﬁles and liberty
(CNIL, commissionNationale de l’Informatique et des Libertes).
Statistical analysis
Quantitative variables were described using the mean ( SD)
for normally distributed data, the median (interquartile range)
for non-normally distributed data and frequency and percentage
for qualitative variables. Comparisons of qualitative variables
were assessed using the Student’s t-test, analysis of variance and
Kruskal–Wallis’s test as appropriate. Qualitative variables were
compared with the chi-square test or Fisher’s exact test as
appropriate. Parameters from centres A and Bweremixed after
having veriﬁed absence of difference between the both centres
(data not shown). Two logistic regression analyses were used
to identify independent risk factors associated with the
probability of GNBm and with the probability of mortality. All
relevant variables achieving a p value <0.05 in the univariate
analysis were proposed in a backward stepwise model.
Postoperative survival times were assessed from the date of
mediastinal debridement to the date of death or the date of
departure of the hospital for censored observation. Survival
curves were computed according to Kaplan–Meier and
compared with the log-rank test. Values of p <0.05 were
considered to be signiﬁcant. The R.2.14.1 statistical software
was used for all analyses [17].
Results
Microbiological results
During this study, 15 237 cardiac surgical procedures were
performed. There were 309 patients (2.03%) that experienced
postoperative mediastinitis (centre A, n = 127/7098; centre B,
n = 182/8139). Three hundred and sixty-four pathogens were
identiﬁed in 305 patients (98.7%). In four patients (1.3%) no
pathogen was recovered (Table 1). The 364 pathogens identi-
ﬁed were split as followed: methicillin-susceptible Staphylococcus
aureus (MSSA) (n = 116, 31.9%), GNB (n = 103, 28.3%),
coagulase-negative Staphylococcus (n = 68, 18.7%), Streptococcus
(n = 31, 8.5%), MRSA (n = 25, 6.9%), and other pathogens
(n = 21, 5.8%). In the GNB group, 103 pathogens were isolated.
Enterobacteriaceae were the most frequent GNB involved:
Escherichia coli (n = 23, 22.3%), Klebsiella pneumoniae (n = 19,
18.5%), Enterobacter cloacae (n = 19, 18.5%), Proteus mirabilis
(n = 8, 7.8%), Serratia marcescens (n = 6, 5.8%), Citrobacter koseri
(n = 6, 5.8%), Enterobacter aerogenes (n = 5, 4.8%), Morganella
morganii (n = 3, 2.9%), Proteus vulgaris (n = 1, 1.0%) and Hafnia
alvei (n = 1, 1.0%). Other GNB associated with mediastinitis
were Pseudomonas aeruginosa (n = 6, 5.8%), Haemophilius inﬂu-
enzae (n = 3, 2.9%), Bacteroides fragilis (n = 2, 1.9%) and
Stenotrophomonas maltophilia (n = 1, 1.0%).
Among these 309 cases of mediastinitis, 262 were monomi-
crobial and 47 were polymicrobial. Polymicrobial mediastinitis
was documented with four microorganisms in two cases (4.3%),
three microorganisms in eight cases (17.0%) and two microor-
ganisms in 37 cases (78.7%). GNB were involved in 40 (85%) of
these 47 cases of polymicrobial mediastinitis: multiple GNB
(n = 10, 21.3%) or GNB associated with Gram-positive cocci
(n = 30, 63.8%). Enterobacteriaceae were the most frequent
pathogens associated with polymicrobial mediastinitis (n = 36,
76.6%). Bacteraemia occurred in 173 (56.0%) of the 309 cases of
mediastinitis.
Demographic, clinical and microbiological features of GNBm
We compared demographic, clinical and microbiological data
of GNBm with mediastinitis due to other pathogens (Table 2).
GNBm occurred more often in women (p 0.02), and were
more frequently polymicrobial (44.0% (n = 40) versus 3.2%
(n = 7); p <0.0001). No other difference between the two
groups was identiﬁed. The sole independent risk factor of
GNBm identiﬁed by multivariate analysis was female sex
(OR = 2.02, 95% CI 1.15–3.55; p 0.01).
Appropriateness of initial antibiotherapy and GNBm
Appropriateness of antimicrobial therapy could be evaluated
among 304 of the 309 patients (98.4%). Initial antimicrobial
TABLE 1. Microbiological analysis of the 309 cases of med-
iastinitis
All mediastinitis with
364 pathogens
GNB, n (%) 103 (28.3)
MSSA, n (%) 116 (31.9)
MRSA, n (%) 25 (6.9)
CNS, n (%) 68 (18.7)
Streptococcus, n (%) 31 (8.5)
Other pathogens, n (%) 21 (5.8)
Polymicrobial, n (%) 47 (15.2)
No. of pathogens isolated n (%) 4 (1.3)
Multi-resistant bacteriaa, n (%) 68 (22.0)
CNS, coagulase-negative staphylococcus; GNB, Gram-negative bacteria; MSSA,
methicillin susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylo-
coccus aureus.
aIncluding MRSA.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O197–O202
CMI Charbonneau et al. Increased mortality with GNB-mediastinitis O199
therapy was inappropriate in 24.6% (n = 22) of the GNB group
and in1.9% (n = 4) of thenon-GNBgroup (p <0.0001). Regarding
polymicrobial mediastinitis, antimicrobial therapywasmore often
inappropriate compared with monomicrobial mediastinitis
(34.7% (n = 16/46) versus 3.9% (n = 10/258), p <0.0001). Mul-
tivariate analysis showed that GNBm (OR = 8.58, 95% CI 2.53–
29.02; p 0.0006) andpolymicrobialmediastinitis (OR = 4.52, 95%
CI 1.68–12.12; p 0.0028) were independent risk factors of
inappropriateness of initial antimicrobial therapy.
GNBm outcome
Regarding postoperative outcome, the failure of drainage, the
occurrence of a complicated ICU course, secondary infection
and mortality were signiﬁcantly more frequent with GNBm.
However, duration of drainage and hospital length of stay were
comparable (Table 3).
Thirty days after mediastinitis debridement, death occurred
in 29 (31.9%) of 91 patients in the GNB group and in 37
(17.0%) of 218 patients in the non-GNB group (p 0.004). The
overall mortality was 21% (n = 66).
Survival using Kaplan–Meier method showed a signiﬁcant
statistical difference between GNB and other mediastinitis
(Fig. 1). Death was directly related to the mediastinitis
(including mediastinal septic shock or major mediastinal
bleeding) in 33 patients (50%), the other causes of death were
other causes of septic shock (13 patients, 19.7%), acute
haemorrhage (three patients, 4.5%), neurological accidents
(four patients, 6.1%), acute heart failure (three patients, 4.5%),
and ten cases of others causes (15.2%).
The median time from the initial surgery to mediastinitis
debridement was 14 (10–21) days for the survivors and 11 (8–
22) days for the non-survivors (p 0.066).
To identify risk factors of mortality, univariate analysis of
preoperative, procedure-related, postoperative variables was
performed by comparing different subsets of patients. All the
TABLE 2. Demographic and surgical characteristics of med-
iastinitis caused by Gram-negative bacteria (GNB)
All
(n = 309)
GNB
(n = 91)
Other
pathogens
(n = 218) p
Demographic characteristics
Mean age, years (IQR) 67 (57–75) 67 (56–74) 67 (58–75) 0.69
Female sex 74 (23.9) 30 (33.0) 44 (20.2) 0.02
Obesity
(BMI >30 kg/m2)
81 (32.4) 31 (38.3) 50 (29.6) 0.37
Chronic pulmonary
disease
41 (13.3) 12 (13.2) 29 (13.3) 0.98
Diabetes 126 (41.0) 44 (48.9) 82 (37.8) 0.07
Extracardiac
arteriopathy
70 (22.7) 21 (23.1) 49 (22.5) 0.91
Preoperative renal
insufﬁciencya
29 (9.4) 8 (8.9) 21 (9.7) 0.83
Median EuroSCORE,
standard
(+1 point) (IQR)
6 (3–8) 6 (3.5–8) 5 (3–7) 0.11
Immunosuppressive
agents
9 (2.9) 3 (3.3) 6 (2.8) 0.73
Median left ventricle
Function,% (IQR)
60 (45–60) 60 (40–60) 60 (49–60) 0.45
Previous cardiac
surgery
34 (11) 12 (13.2) 22 (10.1) 0.44
Surgical characteristics
Isolated CABG 174 (56.3) 49 (53.8) 125 (57.3) 0.57
CABG + valve
procedure
26 (8.4) 9 (9.9) 17 (7.8) 0.55
Use of internal
mammary
arteries
192 (62.1) 56 (61.5) 136 (62.4) 0.89
Isolated valve
replacement
85 (27.5) 25 (27.5) 60 (27.5) 0.99
Emergency surgery 24 (7.8) 8 (8.8) 16 (7.4) 0.67
Median bypass time,
min (IQR)
85 (65–114) 83 (65–106) 87 (65–115) 0.74
Median duration of
ischaemia, min (IQR)
57 (45–73) 58 (44–71) 57 (46–73) 0.79
Reoperation for
bleeding
39 (12.6) 12 (13.2) 27 (12.4) 0.85
Time of onset
to mediastinitis,
0.12
<14 days 175 (57.9) 57 (64.8) 118 (55.1)
≥14 days 127 (42.1) 31 (35.2) 96 (44.9)
Data are number (%) of patients, unless otherwise indicated. BMI, body mass
index; GNB, Gram-negative bacteria; IQR, interquartile range; CABG, coronary
artery bypass graft.
aRenal Insufﬁciency deﬁned by creatinine >200 lM.
TABLE 3. Postoperative evolution after debridement
All (n = 309) GNB (n = 91)
Others
pathogens
(n = 218) p
Median length of
stay, days (IQR)
40 (0–170) 38 (1–170) 41 (0–136) 0.89
Median duration of
drainage, days (IQR)
21 (0–70) 19 (0–70) 21 (0–62) 0.114
Failure of drainage 19 (6.2) 10 (11.0) 9 (4.1) 0.023
Complicated ICU
course
102 (33.0) 38 (41.8) 64 (29.4) 0.035
Secondary infection 42 (13.6) 20 (22.0) 22 (10.1) 0.005
Endocarditis 14 (4.5) 3 (3.3) 11 (5.0) 0.71
Death 66 (21.4) 29 (31.9) 37 (17.0) 0.004
Data are number (%) of patients, unless otherwise indicated. ICU, Intensive care
unit; IQR, interquartile range. Failure of drainage was deﬁned as secondarily
infected Redon catheters and/or failure of aspirating Redon catheters; Compli-
cated ICU course was deﬁned as the need for mechanical ventilation for more than
3 days and/or the use of vasopressors.
FIG. 1. Kaplan–Meier estimates of the probability of survival. GNB,
Gram-negative bacteria.
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variables signiﬁcantly associated with death in the univariate
analysis were integrated into the multivariate analysis (age, sex,
preoperative renal insufﬁciency, previous cardiac surgery,
isolated valve replacement, coronary artery bypass graft, use
of one or both internal mammary arteries, median bypass time,
GNBm, failure of drainage and complicated ICU course).
Backward logistic regression found six independent risk factors
of mortality: age, baseline renal insufﬁciency, isolated valve
replacement surgery, failure of drainage, a complicated ICU
course and GNBm (Table 4). We performed two other
univariate analyses where the appropriateness of initial antib-
iotherapy was adjusted and where patients with inappropriate
initial antibiotherapy were excluded. In both cases, the
multivariate analysis results did not change.
Discussion
In this large cohort of patients, GNBm were frequent, often
polymicrobial and frequently associated with an inappropriate
initial antimicrobial therapy. GNBm were associated with a
high rate of complications such as drainage failure, secondary
infection, prolonged mechanical ventilation and/or use of
vasopressor and increase of mortality rate.
The microbiological characteristics of mediastinitis in this
study are similar to those previously reported [2,11,13,18,19].
The most common pathogen involved was MSSA followed by
GNB. MRSA rate was slightly lower than reported rates in
some recent studies [13,16, 20]. However, the relative
frequency of pathogens could be affected by several factors,
such as local bacterial ecology, institutional antibiotic policy or
both. These variations could partially explain the discrepancy
between pathogens reported in different studies. Data about
identiﬁed GNB are scarce. In our study, Enterobacteriaceae
were the most frequent GNB identiﬁed. Chen et al. [19] found
similar results, but these authors do not distinguish medias-
tinitis from other postoperative infections, such as blood-
stream infections and superﬁcial wound infections.
The mechanisms of mediastinal inoculation by GNB are
unclear. The use of a vein graft harvested from a contaminated
donor site in coronary artery bypass surgery has been
proposed as an explanation [18]. However, this mechanism
could not take in account all GNBm. GNBm has been shown
to be associated with concomitant infections, especially
pneumonia or bacteraemia [21]. Chen et al. [19] demonstrated
that patients with major postoperative infections due to GNB
have higher rates of renal failure, vascular disease, myocardial
infarction, repeat surgery and immunosuppressive treatment,
with longer postoperative length of stay. However, in our
study, we identiﬁed only female sex as an independent risk
factor of GNBm. This unexpected result could not be easily
explained. We could hypothesize that women have higher
prevalence rates of GNB urinary tract infection or coloniza-
tion, but we did not have any data supporting that assumption.
GNBm is not associated with time to onset of mediastinitis in
this work, as in the study by Mekonto Dessap et al. [16].
In this study, GNBm is an independent risk factor of
mortality. This result was not previously reported. Chen et al.
[19] have found that GNB infections are independently
associated with postoperative mortality in all patients who
underwent cardiac surgery, but not when compared with
other pathogens in patients with postoperative infections.
Inappropriateness of initial antibiotherapy may explain, in part,
the worse outcome of GNBm. We identiﬁed GNBm as an
independent risk factor of inappropriate initial antimicrobial
therapy. In patients with septic shock, initial inappropriate
antibiotherapy is associated with a ﬁvefold decrease in survival
[22]. Zahar et al. [23] showed that, in patients with severe
sepsis, the characteristics of the infectious process (site and
causative organism) were not associated with mortality, but
early appropriate antimicrobial therapy was consistently asso-
ciated with better survival.
Our study had some limitations. This study might have
yielded different results if we had included additional data such
as the delay between the ﬁrst clinical signs of infection and the
initiation of antibiotics or surgical debridement. Unfortunately,
these data cannot be reliably provided regarding the retro-
spective design of this study. Moreover, despite a large cohort
of patients, it was not possible to calculate a mortality rate for
each type of GNB involved.
In conclusion, we showed that GNBm was associated with
more severe outcome leading to decrease in survival. No
alterable risk factor for GNBm was observed. However, we
supported that this severe outcome was partly related to an
inappropriateness of initial antimicrobial therapy. This result
emphasizes the importance of knowledge of the local ecology
in the choice of empirical antibiotherapy and the necessity of
the earliest identiﬁcation of the involved pathogens to allow
TABLE 4. Multivariate analysis of the risk factors for death
after mediastinitis in the intensive care unit
OR (95% CI) p
Age 1.07 (1.04–1.11) 0.0001
Preoperative renal insufﬁciency 3.58 (1.34–9.51) 0.0107
Isolated valve replacement 2.25 (1.11–4.49) 0.0253
Complicated ICU course 6.33 (3.17–12.63) <0.0001
Failure of drainage 3.94 (1.19–13.04) 0.0245
Presence of Gram-negative bacteria 2.31 (1.16–4.61) 0.0179
Results of multivariate analysis after logistic regression: n = 309; 66 non-survivors
and 243 survivors.
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determination of their susceptibility to antibiotics. A more
frequent use of antibiotics directed against resistant GNB
should be considered according to local microbial environ-
ment.
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